(±)-Methadone-d3 (CRM) (Synonyms: DL-Methadone-d3) |
| رقم الكتالوجGC91666 |
(±)-Methadone-d3 (CRM) is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 60263-63-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(±)-Methadone-d3 (CRM) is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS. (±)-Methadone is categorized as an opioid.[1] It has analgesic activity.[2] Formulations containing (±)-methadone have been used in the treatment of opioid addiction. (±)-Methadone-d3 is regulated as a Schedule II compound in the United States. (±)-Methadone-d3 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References:
[1].Raynor, K., Kong, H., Chen, Y., et al.Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptorsMol. Pharm.45(2)330-334(1994).
[2].He, L., Kim, J., Ou, C., et al.Methadone antinociception is dependent on peripheral opioid receptorsJ. Pain.10(4)369-379(2009).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *